 | • レポートコード：MRC2-11QY07931 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は多系統萎縮症治療薬のグローバル市場について調査・分析したレポートです。種類別（Anle-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多系統萎縮症治療薬の競争状況、市場シェア ・世界の多系統萎縮症治療薬市場：種類別市場規模 2015年-2020年（Anle-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01） ・世界の多系統萎縮症治療薬市場：種類別市場規模予測 2021年-2026年（Anle-138b、AZD-3241、CS-10BR05、NPT-20011、PBT-434、PD-01） ・世界の多系統萎縮症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の多系統萎縮症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の多系統萎縮症治療薬市場分析：米国、カナダ ・ヨーロッパの多系統萎縮症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多系統萎縮症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多系統萎縮症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多系統萎縮症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AFFiRiS AG、AstraZeneca Plc、Corestem Inc、MitoDys Therapeutics Ltd、Modag GmbH、Neuropore Therapies Inc、Prana Biotechnology Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Multiple System Atrophy Therapeutics Market
The global Multiple System Atrophy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Multiple System Atrophy Therapeutics Scope and Market Size
Multiple System Atrophy Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple System Atrophy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Multiple System Atrophy Therapeutics market is segmented into
Anle-138b
AZD-3241
CS-10BR05
NPT-20011
PBT-434
PD-01
Segment by Application, the Multiple System Atrophy Therapeutics market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Multiple System Atrophy Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Multiple System Atrophy Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Multiple System Atrophy Therapeutics Market Share Analysis
Multiple System Atrophy Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Multiple System Atrophy Therapeutics business, the date to enter into the Multiple System Atrophy Therapeutics market, Multiple System Atrophy Therapeutics product introduction, recent developments, etc.
The major vendors covered:
AFFiRiS AG
AstraZeneca Plc
Corestem Inc
MitoDys Therapeutics Ltd
Modag GmbH
Neuropore Therapies Inc
Prana Biotechnology Ltd
…
1 Study Coverage
1.1 Multiple System Atrophy Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Multiple System Atrophy Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Type
1.4.2 Anle-138b
1.4.3 AZD-3241
1.4.4 CS-10BR05
1.4.5 NPT-20011
1.4.6 PBT-434
1.4.7 PD-01
1.5 Market by Application
1.5.1 Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Multiple System Atrophy Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Multiple System Atrophy Therapeutics Revenue 2015-2026
2.1.2 Global Multiple System Atrophy Therapeutics Sales 2015-2026
2.2 Global Multiple System Atrophy Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Multiple System Atrophy Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Multiple System Atrophy Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Multiple System Atrophy Therapeutics Competitor Landscape by Players
3.1 Multiple System Atrophy Therapeutics Sales by Manufacturers
3.1.1 Multiple System Atrophy Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Multiple System Atrophy Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Multiple System Atrophy Therapeutics Revenue by Manufacturers
3.2.1 Multiple System Atrophy Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Multiple System Atrophy Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Multiple System Atrophy Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Multiple System Atrophy Therapeutics Revenue in 2019
3.2.5 Global Multiple System Atrophy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Multiple System Atrophy Therapeutics Price by Manufacturers
3.4 Multiple System Atrophy Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Multiple System Atrophy Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Multiple System Atrophy Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Multiple System Atrophy Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Multiple System Atrophy Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Multiple System Atrophy Therapeutics Sales by Type (2015-2020)
4.1.2 Global Multiple System Atrophy Therapeutics Revenue by Type (2015-2020)
4.1.3 Multiple System Atrophy Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Multiple System Atrophy Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Multiple System Atrophy Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Multiple System Atrophy Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Multiple System Atrophy Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Multiple System Atrophy Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Multiple System Atrophy Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Multiple System Atrophy Therapeutics Sales by Application (2015-2020)
5.1.2 Global Multiple System Atrophy Therapeutics Revenue by Application (2015-2020)
5.1.3 Multiple System Atrophy Therapeutics Price by Application (2015-2020)
5.2 Multiple System Atrophy Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Multiple System Atrophy Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Multiple System Atrophy Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Multiple System Atrophy Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Multiple System Atrophy Therapeutics by Country
6.1.1 North America Multiple System Atrophy Therapeutics Sales by Country
6.1.2 North America Multiple System Atrophy Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Multiple System Atrophy Therapeutics Market Facts & Figures by Type
6.3 North America Multiple System Atrophy Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Multiple System Atrophy Therapeutics by Country
7.1.1 Europe Multiple System Atrophy Therapeutics Sales by Country
7.1.2 Europe Multiple System Atrophy Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Multiple System Atrophy Therapeutics Market Facts & Figures by Type
7.3 Europe Multiple System Atrophy Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Multiple System Atrophy Therapeutics by Region
8.1.1 Asia Pacific Multiple System Atrophy Therapeutics Sales by Region
8.1.2 Asia Pacific Multiple System Atrophy Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Multiple System Atrophy Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Multiple System Atrophy Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Multiple System Atrophy Therapeutics by Country
9.1.1 Latin America Multiple System Atrophy Therapeutics Sales by Country
9.1.2 Latin America Multiple System Atrophy Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Multiple System Atrophy Therapeutics Market Facts & Figures by Type
9.3 Central & South America Multiple System Atrophy Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Multiple System Atrophy Therapeutics by Country
10.1.1 Middle East and Africa Multiple System Atrophy Therapeutics Sales by Country
10.1.2 Middle East and Africa Multiple System Atrophy Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Multiple System Atrophy Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Multiple System Atrophy Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Corporation Information
11.1.2 AFFiRiS AG Description and Business Overview
11.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AFFiRiS AG Multiple System Atrophy Therapeutics Products Offered
11.1.5 AFFiRiS AG Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Multiple System Atrophy Therapeutics Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 Corestem Inc
11.3.1 Corestem Inc Corporation Information
11.3.2 Corestem Inc Description and Business Overview
11.3.3 Corestem Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Corestem Inc Multiple System Atrophy Therapeutics Products Offered
11.3.5 Corestem Inc Related Developments
11.4 MitoDys Therapeutics Ltd
11.4.1 MitoDys Therapeutics Ltd Corporation Information
11.4.2 MitoDys Therapeutics Ltd Description and Business Overview
11.4.3 MitoDys Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Products Offered
11.4.5 MitoDys Therapeutics Ltd Related Developments
11.5 Modag GmbH
11.5.1 Modag GmbH Corporation Information
11.5.2 Modag GmbH Description and Business Overview
11.5.3 Modag GmbH Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Modag GmbH Multiple System Atrophy Therapeutics Products Offered
11.5.5 Modag GmbH Related Developments
11.6 Neuropore Therapies Inc
11.6.1 Neuropore Therapies Inc Corporation Information
11.6.2 Neuropore Therapies Inc Description and Business Overview
11.6.3 Neuropore Therapies Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Neuropore Therapies Inc Multiple System Atrophy Therapeutics Products Offered
11.6.5 Neuropore Therapies Inc Related Developments
11.7 Prana Biotechnology Ltd
11.7.1 Prana Biotechnology Ltd Corporation Information
11.7.2 Prana Biotechnology Ltd Description and Business Overview
11.7.3 Prana Biotechnology Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Products Offered
11.7.5 Prana Biotechnology Ltd Related Developments
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Corporation Information
11.1.2 AFFiRiS AG Description and Business Overview
11.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AFFiRiS AG Multiple System Atrophy Therapeutics Products Offered
11.1.5 AFFiRiS AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Multiple System Atrophy Therapeutics Market Estimates and Projections by Region
12.1.1 Global Multiple System Atrophy Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Multiple System Atrophy Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Multiple System Atrophy Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Multiple System Atrophy Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Multiple System Atrophy Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Multiple System Atrophy Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Multiple System Atrophy Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Multiple System Atrophy Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Multiple System Atrophy Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Multiple System Atrophy Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Multiple System Atrophy Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Multiple System Atrophy Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Multiple System Atrophy Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Multiple System Atrophy Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Multiple System Atrophy Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Multiple System Atrophy Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Multiple System Atrophy Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Multiple System Atrophy Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Multiple System Atrophy Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Multiple System Atrophy Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Multiple System Atrophy Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Multiple System Atrophy Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Multiple System Atrophy Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Multiple System Atrophy Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Multiple System Atrophy Therapeutics Market Segments
Table 2. Ranking of Global Top Multiple System Atrophy Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Anle-138b
Table 5. Major Manufacturers of AZD-3241
Table 6. Major Manufacturers of CS-10BR05
Table 7. Major Manufacturers of NPT-20011
Table 8. Major Manufacturers of PBT-434
Table 9. Major Manufacturers of PD-01
Table 10. Global Multiple System Atrophy Therapeutics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Multiple System Atrophy Therapeutics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Multiple System Atrophy Therapeutics Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Multiple System Atrophy Therapeutics Sales Market Share by Regions (2015-2020)
Table 14. Global Multiple System Atrophy Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Multiple System Atrophy Therapeutics Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Multiple System Atrophy Therapeutics Sales Share by Manufacturers (2015-2020)
Table 17. Global Multiple System Atrophy Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Multiple System Atrophy Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple System Atrophy Therapeutics as of 2019)
Table 19. Multiple System Atrophy Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Multiple System Atrophy Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Multiple System Atrophy Therapeutics Price (2015-2020) (USD/Pcs)
Table 22. Multiple System Atrophy Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Multiple System Atrophy Therapeutics Product Type
Table 24. Date of International Manufacturers Enter into Multiple System Atrophy Therapeutics Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiple System Atrophy Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 27. Global Multiple System Atrophy Therapeutics Sales Share by Type (2015-2020)
Table 28. Global Multiple System Atrophy Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Multiple System Atrophy Therapeutics Revenue Share by Type (2015-2020)
Table 30. Multiple System Atrophy Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Multiple System Atrophy Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 32. Global Multiple System Atrophy Therapeutics Sales Share by Application (2015-2020)
Table 33. North America Multiple System Atrophy Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 34. North America Multiple System Atrophy Therapeutics Sales Market Share by Country (2015-2020)
Table 35. North America Multiple System Atrophy Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Multiple System Atrophy Therapeutics Revenue Market Share by Country (2015-2020)
Table 37. North America Multiple System Atrophy Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 38. North America Multiple System Atrophy Therapeutics Sales Market Share by Type (2015-2020)
Table 39. North America Multiple System Atrophy Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 40. North America Multiple System Atrophy Therapeutics Sales Market Share by Application (2015-2020)
Table 41. Europe Multiple System Atrophy Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Multiple System Atrophy Therapeutics Sales Market Share by Country (2015-2020)
Table 43. Europe Multiple System Atrophy Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Multiple System Atrophy Therapeutics Revenue Market Share by Country (2015-2020)
Table 45. Europe Multiple System Atrophy Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Multiple System Atrophy Therapeutics Sales Market Share by Type (2015-2020)
Table 47. Europe Multiple System Atrophy Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Multiple System Atrophy Therapeutics Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Multiple System Atrophy Therapeutics Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Multiple System Atrophy Therapeutics Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Multiple System Atrophy Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Multiple System Atrophy Therapeutics Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Multiple System Atrophy Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Multiple System Atrophy Therapeutics Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Multiple System Atrophy Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Multiple System Atrophy Therapeutics Sales Market Share by Application (2015-2020)
Table 57. Latin America Multiple System Atrophy Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Multiple System Atrophy Therapeutics Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Multiple System Atrophy Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Multiple System Atrophy Therapeutics Revenue Market Share by Country (2015-2020)
Table 61. Latin America Multiple System Atrophy Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Multiple System Atrophy Therapeutics Sales Market Share by Type (2015-2020)
Table 63. Latin America Multiple System Atrophy Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Multiple System Atrophy Therapeutics Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Multiple System Atrophy Therapeutics Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Multiple System Atrophy Therapeutics Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Multiple System Atrophy Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Multiple System Atrophy Therapeutics Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Multiple System Atrophy Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Multiple System Atrophy Therapeutics Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Multiple System Atrophy Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Multiple System Atrophy Therapeutics Sales Market Share by Application (2015-2020)
Table 73. AFFiRiS AG Corporation Information
Table 74. AFFiRiS AG Description and Major Businesses
Table 75. AFFiRiS AG Multiple System Atrophy Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. AFFiRiS AG Product
Table 77. AFFiRiS AG Recent Development
Table 78. AstraZeneca Plc Corporation Information
Table 79. AstraZeneca Plc Description and Major Businesses
Table 80. AstraZeneca Plc Multiple System Atrophy Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. AstraZeneca Plc Product
Table 82. AstraZeneca Plc Recent Development
Table 83. Corestem Inc Corporation Information
Table 84. Corestem Inc Description and Major Businesses
Table 85. Corestem Inc Multiple System Atrophy Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Corestem Inc Product
Table 87. Corestem Inc Recent Development
Table 88. MitoDys Therapeutics Ltd Corporation Information
Table 89. MitoDys Therapeutics Ltd Description and Major Businesses
Table 90. MitoDys Therapeutics Ltd Multiple System Atrophy Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. MitoDys Therapeutics Ltd Product
Table 92. MitoDys Therapeutics Ltd Recent Development
Table 93. Modag GmbH Corporation Information
Table 94. Modag GmbH Description and Major Businesses
Table 95. Modag GmbH Multiple System Atrophy Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Modag GmbH Product
Table 97. Modag GmbH Recent Development
Table 98. Neuropore Therapies Inc Corporation Information
Table 99. Neuropore Therapies Inc Description and Major Businesses
Table 100. Neuropore Therapies Inc Multiple System Atrophy Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Neuropore Therapies Inc Product
Table 102. Neuropore Therapies Inc Recent Development
Table 103. Prana Biotechnology Ltd Corporation Information
Table 104. Prana Biotechnology Ltd Description and Major Businesses
Table 105. Prana Biotechnology Ltd Multiple System Atrophy Therapeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Prana Biotechnology Ltd Product
Table 107. Prana Biotechnology Ltd Recent Development
Table 108. Global Multiple System Atrophy Therapeutics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 109. Global Multiple System Atrophy Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 110. Global Multiple System Atrophy Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 111. Global Multiple System Atrophy Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 112. North America: Multiple System Atrophy Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. North America: Multiple System Atrophy Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Europe: Multiple System Atrophy Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Europe: Multiple System Atrophy Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Asia Pacific: Multiple System Atrophy Therapeutics Sales Forecast by Region (2021-2026) (K Pcs)
Table 117. Asia Pacific: Multiple System Atrophy Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 118. Latin America: Multiple System Atrophy Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Latin America: Multiple System Atrophy Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Middle East and Africa: Multiple System Atrophy Therapeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. Middle East and Africa: Multiple System Atrophy Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Main Points Interviewed from Key Multiple System Atrophy Therapeutics Players
Table 126. Multiple System Atrophy Therapeutics Customers List
Table 127. Multiple System Atrophy Therapeutics Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Multiple System Atrophy Therapeutics Product Picture
Figure 2. Global Multiple System Atrophy Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Anle-138b Product Picture
Figure 4. AZD-3241 Product Picture
Figure 5. CS-10BR05 Product Picture
Figure 6. NPT-20011 Product Picture
Figure 7. PBT-434 Product Picture
Figure 8. PD-01 Product Picture
Figure 9. Global Multiple System Atrophy Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Multiple System Atrophy Therapeutics Report Years Considered
Figure 14. Global Multiple System Atrophy Therapeutics Market Size 2015-2026 (US$ Million)
Figure 15. Global Multiple System Atrophy Therapeutics Sales 2015-2026 (K Pcs)
Figure 16. Global Multiple System Atrophy Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Multiple System Atrophy Therapeutics Sales Market Share by Region (2015-2020)
Figure 18. Global Multiple System Atrophy Therapeutics Sales Market Share by Region in 2019
Figure 19. Global Multiple System Atrophy Therapeutics Revenue Market Share by Region (2015-2020)
Figure 20. Global Multiple System Atrophy Therapeutics Revenue Market Share by Region in 2019
Figure 21. Global Multiple System Atrophy Therapeutics Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Multiple System Atrophy Therapeutics Revenue in 2019
Figure 23. Multiple System Atrophy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Multiple System Atrophy Therapeutics Sales Market Share by Type (2015-2020)
Figure 25. Global Multiple System Atrophy Therapeutics Sales Market Share by Type in 2019
Figure 26. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type (2015-2020)
Figure 27. Global Multiple System Atrophy Therapeutics Revenue Market Share by Type in 2019
Figure 28. Global Multiple System Atrophy Therapeutics Market Share by Price Range (2015-2020)
Figure 29. Global Multiple System Atrophy Therapeutics Sales Market Share by Application (2015-2020)
Figure 30. Global Multiple System Atrophy Therapeutics Sales Market Share by Application in 2019
Figure 31. Global Multiple System Atrophy Therapeutics Revenue Market Share by Application (2015-2020)
Figure 32. Global Multiple System Atrophy Therapeutics Revenue Market Share by Application in 2019
Figure 33. North America Multiple System Atrophy Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Multiple System Atrophy Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Multiple System Atrophy Therapeutics Sales Market Share by Country in 2019
Figure 36. North America Multiple System Atrophy Therapeutics Revenue Market Share by Country in 2019
Figure 37. U.S. Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Multiple System Atrophy Therapeutics Market Share by Type in 2019
Figure 42. North America Multiple System Atrophy Therapeutics Market Share by Application in 2019
Figure 43. Europe Multiple System Atrophy Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Multiple System Atrophy Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Multiple System Atrophy Therapeutics Sales Market Share by Country in 2019
Figure 46. Europe Multiple System Atrophy Therapeutics Revenue Market Share by Country in 2019
Figure 47. Germany Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Multiple System Atrophy Therapeutics Market Share by Type in 2019
Figure 58. Europe Multiple System Atrophy Therapeutics Market Share by Application in 2019
Figure 59. Asia Pacific Multiple System Atrophy Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Multiple System Atrophy Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Multiple System Atrophy Therapeutics Sales Market Share by Region in 2019
Figure 62. Asia Pacific Multiple System Atrophy Therapeutics Revenue Market Share by Region in 2019
Figure 63. China Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Multiple System Atrophy Therapeutics Market Share by Type in 2019
Figure 86. Asia Pacific Multiple System Atrophy Therapeutics Market Share by Application in 2019
Figure 87. Latin America Multiple System Atrophy Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Multiple System Atrophy Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Multiple System Atrophy Therapeutics Sales Market Share by Country in 2019
Figure 90. Latin America Multiple System Atrophy Therapeutics Revenue Market Share by Country in 2019
Figure 91. Mexico Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Multiple System Atrophy Therapeutics Market Share by Type in 2019
Figure 98. Latin America Multiple System Atrophy Therapeutics Market Share by Application in 2019
Figure 99. Middle East and Africa Multiple System Atrophy Therapeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Multiple System Atrophy Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Multiple System Atrophy Therapeutics Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Multiple System Atrophy Therapeutics Revenue Market Share by Country in 2019
Figure 103. Turkey Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Multiple System Atrophy Therapeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Multiple System Atrophy Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Multiple System Atrophy Therapeutics Market Share by Type in 2019
Figure 110. Middle East and Africa Multiple System Atrophy Therapeutics Market Share by Application in 2019
Figure 111. North America Multiple System Atrophy Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Multiple System Atrophy Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Multiple System Atrophy Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Multiple System Atrophy Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Multiple System Atrophy Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Multiple System Atrophy Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Multiple System Atrophy Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Multiple System Atrophy Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Multiple System Atrophy Therapeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Multiple System Atrophy Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
多発性硬化症治療薬の世界市場（～2026年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…- 多発性骨髄腫治療薬の世界市場（～2026年） Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma i…
- 脊髄性筋萎縮症の世界市場（～2026年） Market Analysis and Insights: Global Spinal Muscular Atrophy Market The global Spinal Muscular Atrophy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Spinal Muscular Atrophy Scope and Market Size Spinal Muscular Atrop…
- 脊髄性筋萎縮症（SMA）治療の世界市場（～2026年） Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration. North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region. Market …
- 多発性骨髄腫に対するCAR-T細胞療法の世界市場（～2026年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…